×
About 28,974 results

ALLMedicine™ Metastatic Breast Cancer Center

Research & Reviews  12,647 results

Phenotypic heterogeneity and metastasis of breast cancer cells.
https://doi.org/10.1158/0008-5472.CAN-20-1799
Cancer Research; Hapach LA, Carey SP et. al.

May 12th, 2021 - While intratumoral genomic heterogeneity can impede cancer research and treatment, less is known about the effects of phenotypic heterogeneities. To investigate the role of cell migration heterogeneities in metastasis, we phenotypically sorted met...

Ossified diagnosis: sarcoidosis masquerading as metastatic breast cancer.
https://doi.org/10.1136/bcr-2020-237516
BMJ Case Reports; MacDonald-Nethercott M, Ples D et. al.

May 11th, 2021 - A 40-year-old woman was referred to the Breast Unit with a solid lump in her right breast. Investigations revealed an invasive lobular carcinoma. The patient underwent a right-sided mastectomy and sentinel lymph node (LN) biopsy, which confirmed a...

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER...
https://doi.org/10.1080/03007995.2021.1923468
Current Medical Research and Opinion; Cuyun Carter G, Sheffield KM et. al.

May 10th, 2021 - Objective This retrospective observational study described baseline characteristics, real-world treatment patterns, and outcomes among patients with metastatic breast cancer treated with abemaciclib in the United States.Methods De-identified elect...

EARN: an ensemble machine learning algorithm to predict driver genes in metastatic brea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105935
BMC Medical Genomics; Mirsadeghi L, Haji Hosseini R et. al.

May 8th, 2021 - Today, there are a lot of markers on the prognosis and diagnosis of complex diseases such as primary breast cancer. However, our understanding of the drivers that influence cancer aggression is limited. In this work, we study somatic mutation data...

Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systemat...
https://doi.org/10.12788/cutis.0223
Cutis Johnson C, Friedmann DP et. al.

May 6th, 2021 - Metastatic breast cancer initially may present with cutaneous lesions. The goal of this systematic review was to evaluate available reports where the initial discovery of primary breast cancer occurred through the diagnosis of metastatic cutaneous...

see more →

Guidelines  195 results

ESMO Guideline for Cancer Patient Management During the COVID-19 Pandemic
https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic?hit=ehp

Sep 17th, 2020 - These recommendations should be used as guidance for prioritising the various aspects of cancer care in order to mitigate the negative effects of the COVID-19 pandemic on the management of cancer patients. The situation is evolving, and pragmatic ...

Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study
https://www.journal-of-cardiology.com/article/S0914-5087(20)30271-9/fulltext
Journal of Cardiology; Kwak S

Aug 25th, 2020 - Patients with heart failure (HF) are more at risk of developing cancer than the general population.

ECOG-ACRIN Trial Reassures Clinicians, Patients That Locoregional Therapy Is Not Beneficial for Stage IV Metastatic Breast Cancer
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200218/full/

Jun 23rd, 2020 - For patients with stage IV metastatic breast cancer and an intact primary tumor (ITP), the early initiation of locoregional treatment (LRT) was not associated with longer survival or improvements in health-related quality of life (HRQoL) compared ...

see more →

Drugs  405 results see all →

Clinicaltrials.gov  14,475 results

Phenotypic heterogeneity and metastasis of breast cancer cells.
https://doi.org/10.1158/0008-5472.CAN-20-1799
Cancer Research; Hapach LA, Carey SP et. al.

May 12th, 2021 - While intratumoral genomic heterogeneity can impede cancer research and treatment, less is known about the effects of phenotypic heterogeneities. To investigate the role of cell migration heterogeneities in metastasis, we phenotypically sorted met...

Ossified diagnosis: sarcoidosis masquerading as metastatic breast cancer.
https://doi.org/10.1136/bcr-2020-237516
BMJ Case Reports; MacDonald-Nethercott M, Ples D et. al.

May 11th, 2021 - A 40-year-old woman was referred to the Breast Unit with a solid lump in her right breast. Investigations revealed an invasive lobular carcinoma. The patient underwent a right-sided mastectomy and sentinel lymph node (LN) biopsy, which confirmed a...

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER...
https://doi.org/10.1080/03007995.2021.1923468
Current Medical Research and Opinion; Cuyun Carter G, Sheffield KM et. al.

May 10th, 2021 - Objective This retrospective observational study described baseline characteristics, real-world treatment patterns, and outcomes among patients with metastatic breast cancer treated with abemaciclib in the United States.Methods De-identified elect...

EARN: an ensemble machine learning algorithm to predict driver genes in metastatic brea...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105935
BMC Medical Genomics; Mirsadeghi L, Haji Hosseini R et. al.

May 8th, 2021 - Today, there are a lot of markers on the prognosis and diagnosis of complex diseases such as primary breast cancer. However, our understanding of the drivers that influence cancer aggression is limited. In this work, we study somatic mutation data...

Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systemat...
https://doi.org/10.12788/cutis.0223
Cutis Johnson C, Friedmann DP et. al.

May 6th, 2021 - Metastatic breast cancer initially may present with cutaneous lesions. The goal of this systematic review was to evaluate available reports where the initial discovery of primary breast cancer occurred through the diagnosis of metastatic cutaneous...

see more →

News  1,223 results

NICE Draft Guidance on New Treatment Option for Advanced Breast Cancer
https://www.medscape.com/viewarticle/949716

Apr 21st, 2021 - The National Institute for Health and Care Excellence (NICE) has published draft guidance recommending trastuzumab deruxtecan for use in the Cancer Drugs Fund (CDF) as an option for treating HER2-positive unresectable or metastatic breast cancer i...

How Has COVID-19 Affected Metastatic Breast Cancer Treatment Decisions?
https://www.medscape.com/viewarticle/946340

Feb 25th, 2021 - Patients with metastatic breast cancer (MBC) face an elevated risk of severe illness or dying from COVID-19. Given the slow rollout of the Moderna and Pfizer COVID vaccines and new, more infectious viral variants circulating in the United States, ...

Obesity 'Clearly' Not Tied to Worse Survival in MBC
https://www.medscape.com/viewarticle/944913

Jan 28th, 2021 - The relationship between obesity and overweight and breast cancer has some elements of mystery. But this is not one of them: in metastatic breast cancer (MBC), excess body weight does not negatively influence outcomes. Multiple small studies have ...

Margetuximab for HER2+ Metastatic Breast Cancer Falls Short
https://www.medscape.com/viewarticle/943233

Jan 6th, 2021 - This transcript has been edited for clarity. Happy holidays, everyone. This is Dr Kathy Miller from Indiana University. I want to make sure you've had a chance to think carefully about the margetuximab approval by the US Food and Drug Administrati...

CONTESSA: Oral Taxane Meets Primary Endpoint
https://www.medscape.com/viewarticle/943090

Jan 5th, 2021 - This transcript has been edited for clarity. Hi. It's Dr Kathy Miller with more exciting news from the San Antonio Breast Cancer Symposium. I'm talking about the use of oral taxane therapy. You all know that the taxanes are a mainstay of our treat...

see more →

Patient Education  29 results see all →